Key result
R0 resection in the first surgery for retroperitoneal liposarcoma improved 5-year recurrence-free survival compared to non-R0 resection.
Why the study?
The characteristics of primary and repeated recurrent retroperitoneal liposarcoma needed to be investigated.
Does R0 resection improve recurrence-free survival in patients with primary retroperitoneal liposarcoma compared to non-R0 resection?
Cohort (n=52)
No
Does R0 resection improve recurrence-free survival in patients with primary retroperitoneal liposarcoma compared to non-R0 resection?
This is the authors' abstract. We don't add key points for this paper.
OBJECTIVE: This study sought to investigate the characteristics of primary and repeated recurrent retroperitoneal liposarcoma. METHODS: Patients treated with primary or recurrent retroperitoneal liposarcoma between 2005 and 2018 were retrospectively reviewed. Survival time analysis of recurrence-free survival and overall survival was conducted using Kaplan-Meier analysis and log-rank test. RESULTS: Fifty-two patients with primary retroperitoneal liposarcoma were analysed. Amongst them, 46 patients (88%) had undergone surgery. Histologic grades included well-differentiated (n = 21), dedifferentiated (n = 21), myxoid (n = 3) and pleomorphic (n = 1) subtypes. The patients undergoing R0 resection in the first surgery had significantly higher recurrence-free survival rates compared with the patients undergoing non-R0 resection (3-year recurrence-free survival: 80 versus 38%; 5-year recurrence-free survival: 49 versus 29%, P = 0.033). Although overall survival rates tended to be higher in the patients undergoing R0 resection compared with the non-R0 resection, it did not reach to a statistical significant difference (5-year overall survival: 93 versus 75%; 10-year overall survival: 93 versus 59%, P = 0.124). The recurrence rates were 65, 67, 73 and 100%, and the median recurrence-free survival times were 46, 20, 9 and 3 months after the first, second, third and fourth surgeries, respectively. The 5-year overall survival rates were 82, 69, 40 and 0% after the first, second, third and fourth surgeries, respectively. CONCLUSIONS: With repeated recurrence and surgeries, the time to recurrence decreased and the recurrence rate increased. R0 resection in the first surgery was considered the most important for longer recurrence-free survival and radical cure.
Answers are grounded in this paper and cite their sources.
R0 resection during the initial surgery for primary retroperitoneal liposarcoma is associated with significantly improved recurrence-free survival, whereas repeated surgeries for recurrences yield progressively shorter recurrence-free intervals.
No takes yet. Share an insight, caveat, or question.
Ishii et al. (2020) conducted a cohort in Retroperitoneal liposarcoma (n=52). R0 resection vs. non-R0 resection was evaluated on 5-year recurrence-free survival (p=0.033). R0 resection in the first surgery for retroperitoneal liposarcoma improved 5-year recurrence-free survival compared to non-R0 resection.
Synapse has enriched 10 related papers. Consider them for comparative context: